Skyrizi 360 MG/2.4 ML on-body 2.4ML

Ended Awarded Last action

Contract number
SPE2DR26F0BSE
Awardee
Awarding agency
Obligated
$12,467

Award facts

Contract value 100% obligated
$12,467.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $12,467 delivery order to AmerisourceBergen Drug Corp on April 23, 2026, for SKYRIZI 360 mg/2.4 ml on-body injectable pharmaceutical supply with an ultimate completion date of May 14, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor and medical supplier operating under the DLA Troop Support Medical indefinite delivery contract structure serving Defense Health Agency and military medical facilities globally.

Quick answers

Who was awarded contract SPE2DR26F0BSE?

SPE2DR26F0BSE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2026.

How much is contract SPE2DR26F0BSE worth?

The government has obligated $12,467 on SPE2DR26F0BSE.

Is contract SPE2DR26F0BSE an order under another contract?

Yes. SPE2DR26F0BSE is a delivery order under SPE2DR25D2206, an indefinite delivery contract.

Was contract SPE2DR26F0BSE competed?

The extent of competition for SPE2DR26F0BSE was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award